Wegovy (semaglutide) injection 2.4 mg is an injectable prescription medicine used with a reduced calorie diet and increased physical activity: to treat adults with metabolic dysfunction-associated steatohepatitis (MASH) with moderate to advanced liver scarring (fibrosis), but not with cirrhosis of the liver This indication is approved based on improvement of MASH and liver scarring (fibrosis)
If want additional benefits may increase slowly until achieving a final daily dose of 2-4 gm for maximum benefits
Longevity clinics charge premium prices to administer it
Align primary care, endocrine support, and pregnancy care so no major issue gets missed
Exendin-4 bound to same receptors as GLP-1, stimulated insulin secretion in rodents, and lasted longer in the body thanks to a mutation that protects it from being cut up by enzymes
This research-backed guide explains why semaglutide-related weight gain happens, summarizes the best evidence, and gives you a practical plan to use with your care team